MicroRNAs (miRNAs) are small regulatory molecules post-transcriptionally suppressing
mRNA activity. Many miRNAs in various organisms have been cloned but many unknown …

After ischemic stroke, there is a significant burden of cardiovascular complications, both in
the acute and chronic phase. Severe adverse cardiac events occur in 10% to 20% of …

Atrial fibrillation (AF) can be newly detected in approximately one-fourth of patients with
ischemic stroke and transient ischemic attack without previously recognized AF. We present …

The last decade has witnessed remarkable advances in pharmacological and
nonpharmacological strategies for stroke prevention in patients with atrial fibrillation …

Ischemic stroke in patients with atrial fibrillation is associated with substantial morbidity and
mortality. The growing epidemic of atrial fibrillation worldwide has raised concerns about the …

Anticoagulation substantially reduces the risk of stroke in patients with atrial fibrillation (AF).
However, recent studies have shown that up to 22%–36% of patients on anticoagulation will …

Atrial fibrillation (AF) significantly increases the risk of stroke and, therefore, stroke
prevention is an essential component of the management for patients with AF. This requires …

Patent foramen ovale (PFO) describes a valve in the interatrial septum that permits shunting
of blood or thrombotic material between the atria. PFOs are present in approximately 25% of …

Atrial fibrillation (AF) patients are at high risk of stroke, with the left atrial appendage (LAA)
found to be the most common site of clot formation. Presence of left atrial (LA) fibrosis has …

Objective Guidelines recommend initiating anticoagulation within 4 to 14 days after
cardioembolic stroke. Data supporting this did not account for key factors potentially affecting …